Skip to main content
. 2018 May 25;6(5):2325967118774509. doi: 10.1177/2325967118774509

TABLE 3.

Ceiling and Floor Effectsa

  Baseline 6 Weeks 6 Months 2 Years
Ceiling Floor Ceiling Floor Ceiling Floor Ceiling Floor
EQ-5D 4 (2.9) 0 (0.0) 13 (9.4) 0 (0.0) 41 (29.5) 0 (0.0) 50 (45.1)  0 (0.0)
MARS 65 (46.8) 7 (5.0) 61 (43.9) 11 (7.9) 42 (30.2) 17 (12.2) 18 (16.2) 10 (9.0)
KOOS-ADL 6 (4.3) 0 (0.0) 5 (3.6) 1 (0.7) 53 (38.1) 0 (0.0) 50 (45.1)  0 (0.0)
KOOS-sport 3 (2.2) 16 (11.5) 14 (10.1) 10 (7.2) 18 (13.0) 0 (0.0) 30 (27.0) 1 (0.9)
KOOS-QOL 3 (2.2) 13 (9.4) 0 (0.0) 2 (1.4) 3 (2.2) 1 (0.7) 18 (16.2)  0 (0.0)
SF-36 PF 13 (9.4) 1 (0.7) 0 (0.0) 1 (0.7) 14 (10.1) 0 (0.0) 46 (41.4)  0 (0.0)
SF-36 pain 5 (3.6) 0 (0.0) 5 (3.6) 0 (0.0) 35 (25.2) 0 (0.0) 46 (41.4)  0 (0.0)
PROMIS PF CAT 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 2 (1.4) 0 (0.0) 10 (9.0)  0 (0.0)

aData are shown as n (%). ADL, activities of daily living; EQ-5D, EuroQol–5 dimensions questionnaire; KOOS, Knee injury and Osteoarthritis Outcome Score; MARS, Marx Activity Rating Scale; PF, physical function; PROMIS PF CAT, Patient-Reported Outcomes Measurement Information System physical function computer adaptive test; QOL, quality of life; SF-36, Short Form–36 Health Survey.